These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 33506730

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database Analysis.
    Guo A, Niyazov A, Macaulay D, Terasawa E, Schmerold L, Wu EQ, Krieger S.
    J Manag Care Spec Pharm; 2017 Jul; 23(7):771-780. PubMed ID: 28650249
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
    Brummett CM, England C, Evans-Shields J, Kong AM, Lew CR, Henriques C, Zimmerman NM, Pawasauskas J, Oderda G.
    J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States.
    Pizzicato LN, Xie RZ, Yang Y, Grabner M, Chapman RH.
    J Manag Care Spec Pharm; 2023 Jun; 29(6):614-625. PubMed ID: 37276037
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis.
    Culpepper L, Martin A, Nabulsi N, Parikh M.
    Adv Ther; 2024 May; 41(5):1860-1884. PubMed ID: 38466558
    [Abstract] [Full Text] [Related]

  • 52. Effects of Medication Nonadherence and Comorbidity on Health Resource Utilization in Schizophrenia.
    Desai R, Nayak R.
    J Manag Care Spec Pharm; 2019 Jan; 25(1):37-46. PubMed ID: 30589635
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
    Surbhi S, Graetz I, Wan JY, Gatwood J, Bailey JE.
    J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression.
    Olfson M, Amos TB, Benson C, McRae J, Marcus SC.
    J Manag Care Spec Pharm; 2018 Mar; 24(3):226-236. PubMed ID: 29485948
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.
    Hazel-Fernandez L, Louder AM, Foster SA, Uribe CL, Burge RT.
    BMC Musculoskelet Disord; 2013 Jan 03; 14():4. PubMed ID: 23281846
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.